BMRN vs CSBR · P/E 40, rev $2.85B vs P/E 16, rev $56.9M
Biomarin Pharmaceutical Inc (BMRN) versus Champions Oncology Inc (CSBR) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Champions Oncology Inc (CSBR) is a biotechnology company listed on US.
Latest reported BMRN revenue for 2024-12-31 was $2.85B. Net income was $426.9M. Revenue was up 18.0% from 2023-12-31 to 2024-12-31. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported CSBR revenue for 2025-04-30 was $56.9M. Net income was $4.7M. CSBR currently screens at market cap $99.8M and trailing P/E 16.0.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. CSBR currently screens at market cap $99.8M and trailing P/E 16.0.
Not investment advice. Open the BMRN and CSBR stock pages for the full models.
Not investment advice.